Parkinson's disease (PD) is a neurodegenerative disorder primarily affecting the motor system. As healthcare professionals, a comprehensive understanding of PD is essential for effective diagnosis and management.
The exact cause of PD remains unknown. However, it is widely accepted that a combination of genetic and environmental factors plays a significant role. The disease is characterized by the death of dopamine-producing neurons in the substantia nigra, a region in the midbrain, leading to a dopamine deficiency.
PD typically presents with motor symptoms such as bradykinesia, resting tremor, and rigidity. Non-motor symptoms, including autonomic dysfunction, cognitive impairment, and mood disorders, may also be present. The progression of symptoms varies widely among patients.
PD is primarily diagnosed based on clinical criteria, including the presence of bradykinesia and either resting tremor or rigidity. Neuroimaging techniques, such as DaTSCAN, can support the diagnosis, but they are not routinely used due to their high cost and limited availability.
Management of PD focuses on symptomatic treatment. Pharmacotherapy, including levodopa and dopamine agonists, is the mainstay of treatment. Non-pharmacological approaches such as physiotherapy and occupational therapy also play a crucial role. In advanced stages, deep brain stimulation may be considered.
PD is a complex neurodegenerative disorder with a multifaceted clinical presentation. Understanding its etiology, recognizing its symptoms, and being familiar with the current diagnostic and treatment strategies are key to providing optimal care for patients with PD. As we continue to delve deeper into the intricacies of this disease, we can hope to improve both the quality of life and lifespan of those affected.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation